Live Breaking News & Updates on Mark Your Calendar For February

Stay updated with breaking news from Mark your calendar for february. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs


The FDA approved an expansion in the label for
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and
Sanofi SA s (NASDAQ: SNY) immunotherapy Libtayo for treating patients with advanced basal cell carcinoma previously treated with a hedgehog pathway inhibitor, HHI, or for whom an HHI is not appropriate.
Full approval was granted for patients with locally advanced BCC and accelerated approval was granted for patients with metastatic BCC.
Moderna Strikes Vaccine Supply Agreements With Taiwan and Columbia
Moderna Inc (NASDAQ: MRNA) announced two supply agreements for its COVID-19 Vaccine - one with the government of Taiwan for 5 million doses and another with the government of Colombia for 10 million doses. Under the terms of the agreements, deliveries would begin in mid-2021. ....

United States , Vallon Pharma , Pacific Biosciences , Mitchell Horwitz , Eli Lilly And Co , Cassava Sciences Inc , Kamada Ltd , Aptevo Therapeutics Inc , Codiak Biosciences Inc , Mereo Biopharma Group , California Inc , Teva Pharmaceutical Industries Ltd , Exelixis Inc , Moderna Inc , Aethlon Medical Inc , Veru Inc , Gamida Cell Ltd , Protalix Biotherapeutics Inc , Vanda Pharmaceuticals Inc , Regeneron Pharmaceuticals Inc , Abcellera Biologics Inc , Biotechnologies Co , Enlivex Therapeutics Ltd , Fluidigm Corporation , Iterum Therapeutics , Polypid Ltd ,